Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Atypical antipsychotics and diabetic ketoacidosis: a review.

Guenette MD, Hahn M, Cohn TA, Teo C, Remington GJ.

Psychopharmacology (Berl). 2013 Mar;226(1):1-12. doi: 10.1007/s00213-013-2982-3. Epub 2013 Jan 24. Review.

PMID:
23344556
3.

Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics.

Henderson DC, Cagliero E, Copeland PM, Louie PM, Borba CP, Fan X, Freudenreich O, Goff DC.

J Clin Psychiatry. 2007 Apr;68(4):533-41.

PMID:
17474808
4.

[Schizophrenia, diabetes mellitus and antipsychotics].

Gury C.

Encephale. 2004 Jul-Aug;30(4):382-91. Review. French.

PMID:
15538314
5.
6.

Factors in antipsychotic drug selection: tolerability considerations.

Nasrallah HA.

CNS Spectr. 2003 Nov;8(11 Suppl 2):23-5.

PMID:
14978455
7.

Diabetic ketoacidosis in patients exposed to antipsychotics: a systematic literature review and analysis of Danish adverse drug event reports.

Polcwiartek C, Vang T, Bruhn CH, Hashemi N, Rosenzweig M, Nielsen J.

Psychopharmacology (Berl). 2016 Oct;233(21-22):3663-3672. Epub 2016 Sep 4. Review.

PMID:
27592232
8.

Hyperglycemia and antipsychotic medications.

Haupt DW, Newcomer JW.

J Clin Psychiatry. 2001;62 Suppl 27:15-26; discussion 40-1. Review.

9.

New onset diabetes with ketoacidosis attributed to quetiapine.

Marlowe KF, Howard D, Chung A.

South Med J. 2007 Aug;100(8):829-31.

PMID:
17713311
10.

Atypical antipsychotics and glucose homeostasis.

Bergman RN, Ader M.

J Clin Psychiatry. 2005 Apr;66(4):504-14. Review.

PMID:
15816794
11.

Rapid onset of quetiapine-induced diabetic ketoacidosis in an elderly patient: a case report.

Takahashi M, Ohishi S, Katsumi C, Moriya T, Miyaoka H.

Pharmacopsychiatry. 2005 Jul;38(4):183-4.

PMID:
16025424
12.

Diabetic ketoacidosis among patients receiving clozapine: a case series and review of socio-demographic risk factors.

Nihalani ND, Tu X, Lamberti JS, Olson D, Olivares T, Costea GO, Tang W.

Ann Clin Psychiatry. 2007 Apr-Jun;19(2):105-12. Review. Erratum in: Ann Clin Psychiatry. 2007 Oct-Dec;19(4):329. Tu, Xin [added].

PMID:
17612850
13.

Diabetic ketoacidosis associated with aripiprazole.

Church CO, Stevens DL, Fugate SE.

Diabet Med. 2005 Oct;22(10):1440-3.

PMID:
16176209
14.

[Metabolic side effects of risperidone in early onset schizophrenia].

Goeb JL, Marco S, Duhamel A, Kechid G, Bordet R, Thomas P, Delion P, Jardri R.

Encephale. 2010 Jun;36(3):242-52. doi: 10.1016/j.encep.2009.10.008. Epub 2009 Dec 1. French.

PMID:
20620267
15.

Diabetic ketoacidosis associated with aripiprazole.

Makhzoumi ZH, McLean LP, Lee JH, Ibe AI.

Pharmacotherapy. 2008 Sep;28(9):1198-202. doi: 10.1592/phco.28.9.1198.

PMID:
18752391
16.

Fatal diabetic ketoacidosis and antipsychotic medication.

Ely SF, Neitzel AR, Gill JR.

J Forensic Sci. 2013 Mar;58(2):398-403. doi: 10.1111/1556-4029.12044. Epub 2012 Dec 27.

PMID:
23278567
17.

Metabolic consequences of antipsychotic therapy: preclinical and clinical perspectives on diabetes, diabetic ketoacidosis, and obesity.

Heal DJ, Gosden J, Jackson HC, Cheetham SC, Smith SL.

Handb Exp Pharmacol. 2012;(212):135-64. doi: 10.1007/978-3-642-25761-2_6. Review.

PMID:
23129331
19.

Positive predictive value of automated database records for diabetic ketoacidosis (DKA) in children and youth exposed to antipsychotic drugs or control medications: a Tennessee Medicaid Study.

Bobo WV, Cooper WO, Epstein RA Jr, Arbogast PG, Mounsey J, Ray WA.

BMC Med Res Methodol. 2011 Nov 23;11:157. doi: 10.1186/1471-2288-11-157.

20.

Olanzapine-induced diabetic ketoacidosis.

Ragucci KR, Wells BJ.

Ann Pharmacother. 2001 Dec;35(12):1556-8.

PMID:
11793618

Supplemental Content

Support Center